New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
August 14, 2014
17:16 EDTQCOR, DTV, GM, AAL, FCX, DG, CIE, HSH, AGN, HES, CBS, VOD, FDO, SHPG, COV, DLR, PXD, CNO, TMO, MNKPaulson & Co gives quarterly update on stakes
NEW STAKES: Allergan (AGN), DIRECTV (DTV), Covidien (COV), Hillshire Brands (HSH), and Questcor (QCOR). INCREASED STAKES: Shire (SHPG), Cobalt (CIE), Mallinckrodt (MNK), Family Dollar (FDO), and Dollar General (DG). DECREASED STAKES: Thermo Fisher (TMO), Vodafone (VOD), Freeport-McMoRan (FCX), CNO Financial (CNO), and CBS (CBS). LIQUIDATED STAKES: American Airlines (AAL), Pioneer Natural Resources (PXD), Hess (HES), General Motors (GM), and Digital Realty Trust (DLR).
News For AGN;DTV;COV;HSH;QCOR;SHPG;CIE;MNK;FDO;DG;TMO;VOD;FCX;CNO;CBS;AAL;PXD;HES;GM;DLR From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | 5 | all recent news | >>
April 8, 2015
08:04 EDTFDOFamily Dollar reports Q2 adjusted EPS 74c, consensus 73c
Subscribe for More Information
05:49 EDTDGDollar General price target raised to $85 from $80 at Deutsche Bank
Subscribe for More Information
April 7, 2015
16:38 EDTFDODollar Tree discloses update on FTC review process of Family Dollar acquisition
Dollar Tree (DLTR) disclosed in a regulatory filing, the following update on the Federal Trade Commission’s review process of the company’s pending acquisition of Family Dollar Stores (FDO). As of April 1, the FTC’s staff has substantially completed its review and identified approximately 340 stores for divestiture, representing approximately $47.4M of operating income. The company expects that all or almost all of the stores that will be divested will be Family Dollar stores. The company continues to make progress with divestiture buyers and has received multiple indications of interest from buyers, each of whom intend to operate these divested locations as dollar stores to address the FTC's concerns. The company is working to finalize divestiture agreements with the selected bidders in April 2015 and in parallel to secure FTC approval. The company intends to close the proposed merger in May, but this timing is subject to certain factors beyond the company’s control, including FTC approval.
15:30 EDTFDONotable companies reporting before tomorrow's open
Subscribe for More Information
11:27 EDTGMCanadian sale of General Motors stake removes an overhang, says BofA/Merrill
Subscribe for More Information
10:28 EDTVODMavenir announces VoLTE launch with Vodafone Germany
Mavenir Systems (MVNR) announced its VoLTE application solution was launched by Vodafone Germany (VOD), who announced during CEBIT 2015 the first commercially available VoLTE service in the European market. Mavenir’s virtualized VoLTE application solution consists of its IMS Telephony Application Server, Application Gateway and Media Resource Function.
10:19 EDTCBSHigh option volume stocks
Subscribe for More Information
10:10 EDTSHPGJazz patent on Xyrem latest to be challenged by Kyle Bass
Subscribe for More Information
09:23 EDTGMOn The Fly: Pre-market Movers
Subscribe for More Information
09:01 EDTGMGeneral Motors 73.39M share Block Trade priced at $35.90
Subscribe for More Information
08:10 EDTSHPGShire shares pricing in worst case scenario for patents, says Citigroup
Subscribe for More Information
07:13 EDTSHPGShire patent challenges only modest threat, says Jefferies
Subscribe for More Information
06:56 EDTGMGeneral Motors 73.39M share Block Trade; price range $35.80-$36.00
Subscribe for More Information
05:23 EDTSHPGShire reaches agreement with FDA on clear regulatory path for SHP465
Shire announces that it has reached an agreement with the FDA on a clear regulatory path for SHP465, an investigational oral stimulant medication being evaluated as a potential treatment for Attention-Deficit/Hyperactivity Disorder, or ADHD, in adults. Shire has agreed with the FDA to conduct a short-term efficacy and safety study in pediatric patients with ADHD. While Shire intends to pursue an adult indication, the FDA is requesting this additional pediatric data to better understand the potential effects of SHP465 on children with ADHD in the event of use in this population. The company anticipates the clinical trial's first patient, first visit to take place in August 2015, with study completion targeted by the last quarter of 2016. Shire then expects to submit to the FDA by 2Q17 a Class 2 resubmission for approval of SHP465 as a treatment for ADHD in adults, which typically entails a 6-month review. Pending FDA approval, Shire anticipates launching the medicine in the second half of 2017. This update follows Shire's announcement on October 9, 2014, that it was engaging the FDA to determine the parameters of clinical data requirements in order to submit the Class 2 resubmission.
April 6, 2015
18:01 EDTGMCanada GEN Investment to sell 73.39M shares of General Motors to Goldman Sachs
Subscribe for More Information
11:41 EDTGMDeath claims linked to GM ignition switches up to 80, WSJ reports
The number of deaths linked to General Motors' faulty ignition switch was raised by three to 80 total people, reports The Wall Street Journal, citing statements by lawyers operating the GM compensation fund. The number of confirmed injury claims rose by seven to 141 people. Reference Link
09:09 EDTSHPGShire says will defend patents 'vigorously' after Hayman petitions
Subscribe for More Information
08:22 EDTTMOBofA/Merrill life sciences analysts hold an analyst/industry conference call
Subscribe for More Information
07:41 EDTGMBrookings Institute to hold a discussion
Subscribe for More Information
April 5, 2015
08:43 EDTGMAT&T, Philip Morris, eight others have reliable yields up to 5.7%, Barron's says
Subscribe for More Information
1 | 2 | 3 | 4 | 5 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use